Lacosamide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69315-318 -
Package NDC
69315-318-20 -
Package NDC
69315-318-46 -
Application number
ANDA216461 -
SPL ID
0267a67e-d492-480b-a688-e2cec27142a6 -
SPL set ID
45786c84-51ef-4440-bc88-2501951e4c41 -
UNII
563KS2PQY5 -
RxCUI
993856
What the source publishes
- Labeler
- Leading Pharma, LLC
- Active ingredients
- Lacosamide
- Form
- SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lacosamide",
"splId": "0267a67e-d492-480b-a688-e2cec27142a6",
"labels": [
{
"setId": "45786c84-51ef-4440-bc88-2501951e4c41",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45786c84-51ef-4440-bc88-2501951e4c41",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45786c84-51ef-4440-bc88-2501951e4c41"
}
],
"routes": [
"ORAL"
],
"labeler": "Leading Pharma, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "200 mL in 1 BOTTLE, PLASTIC (69315-318-20)",
"package_ndc": "69315-318-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20230725"
},
{
"sample": false,
"description": "465 mL in 1 BOTTLE, PLASTIC (69315-318-46)",
"package_ndc": "69315-318-46",
"identifierStatus": "well-formed",
"marketing_start_date": "20230725"
}
],
"productId": "69315-318_0267a67e-d492-480b-a688-e2cec27142a6",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "69315-318",
"deaSchedule": "CV",
"genericName": "Lacosamide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LACOSAMIDE",
"strength": "10 mg/mL"
}
],
"applicationNumber": "ANDA216461",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230206",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0369315318461"
],
"unii": [
"563KS2PQY5"
],
"rxcui": [
"993856"
],
"spl_set_id": [
"45786c84-51ef-4440-bc88-2501951e4c41"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Leading Pharma, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69315-318_0267a67e-d492-480b-a688-e2cec27142a6"